Efficacy, Safety, and Adequacy of EUS-guided Liver Biopsy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Length of core biopsy
研究概览
简要总结
The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC).
详细描述
The purpose of this study is to evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients undergoing EUS-guided liver biopsy at Methodist Dallas Medical Center (MDMC). This is a clinical quality improvement (CQI) initiative to evaluate outcomes within our institution. The data collected will be used to inform new innovative ways to improve EUS-guided liver biopsy with an ultimate goal of improving the quality of patient care. The clinical outcomes of this patient population have not been previously systematically reviewed in MDMC. Currently, the procedure in not being performed routinely at Methodist Dallas Medical Center (MDMC). However, with new technical and physician expertise, this option is now available at our institution. PI will evaluate the efficacy, safety, and adequacy of EUS-guided liver biopsy in patients requiring histologic examination of their liver at MDMC.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years or older
- •Undergone EUS-guided liver biopsy at MDMC
排除标准
- •Below 18 years of age
- •Did not undergo EUS-guided liver biopsy at MDMC
结局指标
主要结局
Length of core biopsy
时间窗: 9/1/2017 and 9/1/2019
Number of portal tracts
时间窗: 9/1/2017 and 9/1/2019
Diagnostic yield
时间窗: 9/1/2017 and 9/1/2019
We will define an adequate specimen as one containing ≥11 portal tracts or measuring ≥20 mm cumulative core length.
次要结局
未报告次要终点